China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.562
-0.030 (-5.05%)
Mar 6, 2026, 4:00 PM EST - Market closed

China Pharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
34452319
Upgrade
Market Cap Growth
-32.84%12.27%-19.49%-78.32%17.59%88.26%
Upgrade
Enterprise Value
688133026
Upgrade
Last Close Price
0.562.336.0547.95241.30222.90
Upgrade
PS Ratio
0.700.990.570.612.371.79
Upgrade
PB Ratio
0.340.580.541.153.802.43
Upgrade
P/TBV Ratio
-4.250.952.003.892.48
Upgrade
P/FCF Ratio
18.04-----
Upgrade
P/OCF Ratio
12.02-----
Upgrade
EV/Sales Ratio
1.511.721.141.603.102.42
Upgrade
EV/EBITDA Ratio
--4370.46-131.65259.95
Upgrade
EV/FCF Ratio
39.15-----
Upgrade
Debt / Equity Ratio
0.430.460.622.042.080.93
Upgrade
Debt / EBITDA Ratio
--58.59-39.1037.57
Upgrade
Debt / FCF Ratio
22.82-----
Upgrade
Net Debt / Equity Ratio
0.400.380.431.571.270.81
Upgrade
Net Debt / EBITDA Ratio
-2.02-1.501751.33-7.9333.5663.95
Upgrade
Net Debt / FCF Ratio
21.11-5.87-4.51-8.29-11.09-7.11
Upgrade
Asset Turnover
0.280.290.410.400.440.50
Upgrade
Inventory Turnover
2.152.172.052.552.642.44
Upgrade
Quick Ratio
0.080.180.310.200.530.13
Upgrade
Current Ratio
0.350.650.880.470.870.47
Upgrade
Return on Equity (ROE)
-42.98%-62.31%-52.43%-77.08%-48.49%-33.25%
Upgrade
Return on Assets (ROA)
-13.17%-18.29%-10.04%-10.97%-8.17%-7.43%
Upgrade
Return on Capital Employed (ROCE)
-33.60%-46.50%-28.50%-70.40%-23.60%-26.50%
Upgrade
Earnings Yield
-113.08%-105.81%-77.22%-80.22%-14.88%-14.76%
Upgrade
FCF Yield
5.54%-11.28%-17.84%-16.39%-3.01%-4.68%
Upgrade
Buyback Yield / Dilution
-135.14%-416.13%-221.82%-13.96%-5.75%-0.10%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.